Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 20;30(7):685-689.
doi: 10.3760/cma.j.cn501113-20220430-00231.

[Interventional treatment of biliary liver disease]

[Article in Chinese]
K Li  1 , G H Han  2
Affiliations
Review

[Interventional treatment of biliary liver disease]

[Article in Chinese]
K Li et al. Zhonghua Gan Zang Bing Za Zhi. .

Abstract
in English, Chinese

Biliary liver diseases such as intrahepatic cholangiocarcinoma and primary biliary cholangitis seriously endanger the health of patients. Interventional treatments such as hepatic arterial infusion chemotherapy and transjugular intrahepatic portosystemic shunt have the advantages of less surgical trauma, faster recovery, and lower cost than conventional internal medicine and surgical treatments. Thus, they are widely used in biliary liver diseases. This article reviews the interventional treatment of common biliary liver diseases, in an attempt to provide reference for the corresponding clinical diagnosis, treatment and research.

肝内胆管细胞癌、原发性胆汁性胆管炎等胆源性肝脏疾病严重危害患者健康。相较于常规内外科治疗方式，介入治疗，如肝动脉灌注化学治疗、经颈静脉肝内门体分流术等，具有创伤小、恢复快、费用低等优势，已在该领域获得广泛应用。现对常见胆源性肝脏疾病的介入治疗进行综述，为相应的临床诊治及研究提供参考。.

PubMed Disclaimer

Conflict of interest statement

所有作者均声明不存在利益冲突

References

    1. Valle JW, Kelley RK, Nervi B, et al. Biliary tract cancer[J]. Lancet, 2021,397(10272):428-444. DOI: 10.1016/S0140-6736(21)00153-7. - DOI - PubMed
    1. Shroff RT, Kennedy EB, Bachini M, et al. Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline[J]. J Clin Oncol, 2019, 37(12): 1015-1027. DOI: 10.1200/JCO.18.02178. - DOI - PubMed
    1. Inaba Y, Arai Y, Yamaura H, et al. Phase Ⅰ/Ⅱ study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma (JIVROSG-0301)[J]. Am J Clin Oncol, 2011, 34(1): 58-62. DOI: 10.1097/COC.0b013e3181d2709a. - DOI - PubMed
    1. Holster JJ, El Hassnaoui M, Franssen S, et al. Hepatic arterial infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis[J]. Ann Surg Oncol, 2022. DOI: 10.1245/s10434-022-11439-x. - DOI
    1. Ghiringhelli F, Lorgis V, Vincent J, et al. Hepatic arterial infusion of gemcitabine plus oxaliplatin as second-line treatment for locally advanced intrahepatic cholangiocarcinoma: preliminary experience[J]. Chemotherapy, 2013, 59(5): 354-360. DOI: 10.1159/000362223. - DOI - PubMed